Medicared For All Logo

Mezgebe Berhe MD in Dallas, Texas

Home Texas Dallas

Mezgebe Berhe MD has Infectious Disease as his primary medical specialty. Their primary office is: 3409 Worth St in Dallas, Texas.

They're a part of the: North Texas Infectious Diseases Consultants medical group which has around 11 members. You can call their office at 214-823-2533 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1993 (around 31 years of experience). They are listed as doing telehealth appointments.


Mezgebe Berhe MD Office Phone and Directions

Mezgebe Berhe MD
North Texas Infectious Diseases Consultants
3409 Worth St
Dallas, Texas 75246
214-823-2533


Patient Ratings
Please rate your experience with Mezgebe Berhe MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 214-823-2533


Enter a starting address:


Healthcare Info for Mezgebe Berhe MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1993
The Primary Medical Specialty for Mezgebe Berhe MD is listed as: Infectious Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 5092749820
NPI #: 1831155787
NPI Created On: 04/20/2006
NPI Last Updated Listed as: 10/12/2023
Primary Taxonomy Code: 174400000X
License Number:
M1510
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Oscar Insurance Company
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, German, Spanish.


Services and Procedures include:

  1. Insertion of central venous catheter for infusion using imaging guidance, patient 5 years or older
  2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  3. Infusion into a vein for therapy, prevention, or diagnosis
  4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  5. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  6. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
  7. Infusion of chemotherapy into a vein up to 1 hour
  8. Infusion of chemotherapy into a vein
  9. Established patient office or other outpatient visit, typically 5 minutes
  10. Established patient office or other outpatient visit, typically 15 minutes
  11. Established patient office or other outpatient, visit typically 25 minutes
  12. Initial hospital inpatient care, typically 50 minutes per day
  13. Initial hospital inpatient care, typically 50 minutes per day
  14. Initial hospital inpatient care, typically 70 minutes per day
  15. Initial hospital inpatient care, typically 70 minutes per day
  16. Subsequent hospital inpatient care, typically 25 minutes per day
  17. Subsequent hospital inpatient care, typically 25 minutes per day
  18. Subsequent hospital inpatient care, typically 35 minutes per day
  19. Subsequent hospital inpatient care, typically 35 minutes per day
  20. Injection, belatacept, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788726575

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Infectious Diseases & Vaccines

Name of Drug #1: SYMTUZA

Open Associated Drug #1: 59676-800-30


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788726577

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Infectious Diseases & Vaccines

Name of Drug #1: SYMTUZA

Open Associated Drug #1: 59676-800-30


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788726579

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Infectious Diseases & Vaccines

Name of Drug #1: SYMTUZA

Open Associated Drug #1: 59676-800-30


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788726581

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Infectious Diseases & Vaccines

Name of Drug #1: SYMTUZA

Open Associated Drug #1: 59676-800-30


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788726583

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Infectious Diseases & Vaccines

Name of Drug #1: SYMTUZA

Open Associated Drug #1: 59676-800-30


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 813492043

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTIBIOTIC

Name of Drug #1: NUZYRA

Open Associated Drug #1: 71715-002-21


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794046079

Being Disputed:: No

Product Related: No


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794046083

Being Disputed:: No

Product Related: No


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794046087

Being Disputed:: No

Product Related: No


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803215579

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: HIV

Name of Drug #1: CABENUVA

Open Associated Drug #1: 49702-240-15


Infectious Disease Professionals in Dallas

7777 Forest Ln
Dallas, TX
Id Specialists, P.a.

2201 Inwood Rd
Dallas, TX
University Of Texas Southwestern Medical Center

2201 Inwood Rd
Dallas, TX
University Of Texas Southwestern Medical Center

5200 Harry Hines Blvd
Dallas, TX
University Of Texas Southwestern Medical Center

5151 Maple Ave
Dallas, TX
University Of Texas Southwestern Medical Center

6201 Harry Hines Blvd
Dallas, TX
University Of Texas Southwestern Medical Center

Providers in North Texas Infectious Diseases Consultants

1.Ashley Agura

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Physician Assistant

2.Mezgebe Berhe Md

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Infectious Disease

3.Christopher Bettacchi Md

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Infectious Disease

4.Devyani Deshpande

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Infectious Disease

5.Emma Dishner

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Infectious Disease

6.Erin Duhaime

3409 Worth St
Dallas Tx 75246-2060
North Texas Infectious Diseases Consultants
Physician Assistant

View all 11 members of North Texas Infectious Diseases Consultants medical group